Financhill
Sell
35

VS Quote, Financials, Valuation and Earnings

Last price:
$2.10
Seasonality move :
13.88%
Day range:
$2.07 - $2.18
52-week range:
$1.00 - $9.59
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
59.17x
P/B ratio:
0.98x
Volume:
24.7K
Avg. volume:
21K
1-year change:
40.26%
Market cap:
$10.6M
Revenue:
$57.3K
EPS (TTM):
-$1.21

Earnings Data

Next earnings date for VS
Aug 14
2025
Most recent earnings per share
-$0.20
Missed by $0.20
(May 15/2025)
Consensus Estimate
--
(May 15/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

VS Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
05/15/2025 Q1 -- $199.4K -$0.20 -- --
12/31/2024 Q4 -- -- -$0.25 -- --
11/14/2024 Q3 $25K $3.9K -$0.22 -$0.49 $0.27
08/14/2024 Q2 $48.1K $26.9K -$0.54 -$0.50 -$0.04
05/15/2024 Q1 $79.1K $26.5K -$0.53 -$0.49 -$0.04
12/31/2023 Q4 $120K $34.2K -$1.80 -$1.14 -$0.66
11/14/2023 Q3 $206K $23K -$1.99 -$2.88 $0.89
06/30/2023 Q2 $276.1K $56.1K -$3.05 -$4.80 $1.75
03/31/2023 Q1 $372.3K $158K -$2.28 -$5.92 $3.64
12/31/2022 Q4 $495.5K $217.6K -$47.48 -$23.98 -$23.50
11/15/2022 Q3 $563K $316.8K -$28.64 -$31.15 $2.51
08/16/2022 Q2 -- $250.7K -$31.20 -- --
05/17/2022 Q1 -- $323.8K -$33.60 -- --
02/28/2022 Q4 -- $393.3K -$38.43 -- --
11/15/2021 Q3 -- $304.7K -$2,052.00 -- --
08/16/2021 Q2 -- $70.4K -$19.20 -- --
05/17/2021 Q1 -- $340 -$249.60 -- --
12/31/2020 Q4 -- $369.6K -$31.20 -- --
09/30/2020 Q3 -- $563.8K -$26.40 -- --
06/30/2020 Q2 -- $456.5K -$50.40 -- --
03/31/2020 Q1 -- $190 -$36.00 -- --
12/31/2019 Q4 -- $6.9K -$61.57 -- --
09/30/2019 Q3 -- -- -$58.01 -- --
06/30/2019 Q2 -- $328.9K -$58.50 -- --
03/31/2019 Q1 -- $166.6K -$57.52 -- --
12/31/2018 Q4 -- -$60 $26.79 -- --
09/30/2018 Q3 -- $1.3K -$59.44 -- --
06/30/2018 Q2 -- -- -$63.64 -- --
03/31/2018 Q1 -- -- -$59.47 -- --
12/31/2017 Q4 -- -- -$54.59 -- --
09/30/2017 Q3 -- -- -$30.95 -- --
06/30/2017 Q2 -- -- -$59.05 -- --
03/31/2017 Q1 -- -- -$33.99 -- --
12/31/2016 Q4 -- -- -$29.88 -- --
09/30/2016 Q3 -- -- -$58.41 -- --
06/30/2016 Q2 -- -- -$89.04 -- --
03/31/2016 Q1 -- -- -$29.58 -- --
12/31/2015 Q4 -- -- -$54.41 -- --
09/30/2015 Q3 -- -- -$28.60 -- --
06/30/2015 Q2 -- -- -$30.94 -- --

Versus Systems Earnings Questions

  • How Much did Versus Systems Generate in Revenue Last Quarter?

    Versus Systems reported $199.4K worth of top line sales in its most recent quarter.

  • Did Versus Systems Beat Earnings Last Quarter?

    Versus Systems announced earnings per share of -$0.20 which represents a miss of analyst forecast a -- per share.

  • Is Versus Systems Profitable?

    Versus Systems reported $191.1K that represents $0.04 per share over the last quarter.

  • What is the Analyst Consensus for Versus Systems EPS Next Year?

    Versus Systems's earnings are forecast to decrease from -$1.54 per share to -$1.65 per share next year representing a decrease of -84.24%.

  • When is Versus Systems's Earnings Date?

    Versus Systems's next earnings date is August 14, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Palantir Stock Overvalued?
Is Palantir Stock Overvalued?

By every traditional yardstick, including a price‑to‑sales well above 100,…

Is Gamestop’s Bitcoin Strategy Going To Succeed?
Is Gamestop’s Bitcoin Strategy Going To Succeed?

When GameStop (NYSE: GME) announced in Q1 that its board had…

How High Will Roku Stock Go?
How High Will Roku Stock Go?

Streaming software and hardware maker Roku (NASDAQ:ROKU) has seen its…

Stock Ideas

Buy
65
Is MSFT Stock a Buy?

Market Cap: $3.5T
P/E Ratio: 40x

Buy
57
Is NVDA Stock a Buy?

Market Cap: $3.5T
P/E Ratio: 48x

Sell
39
Is AAPL Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 32x

Alerts

Sell
11
VEON alert for Jun 14

VEON [VEON] is down 18.57% over the past day.

Buy
74
DAVE alert for Jun 14

Dave [DAVE] is down 12.68% over the past day.

Buy
54
DAR alert for Jun 14

Darling Ingredients [DAR] is up 9.12% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock